z-logo
open-access-imgOpen Access
Polymorphism in coronary artery vasoconstriction
Author(s) -
K Schwartz
Publication year - 2001
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.2000.2530
Subject(s) - medicine , cardiology , vasoconstriction , artery
This, however, should not discourage the cardiologist. Simply measuring diastolic thickening should at least provide an idea of which patients need further sophisticated testing; (5) finally and, perhaps most importantly, the study stressed the importance of the fact that the extent of viability is related to better survival — the bigger the area of hibernation, the better the survival. This point is clinically critical, as a small area of viable myocardium was related to a higher incidence of cell death. Therefore, the cardiologist should aim to reperfuse only when there is enough hibernating myocardium able to recover. I have only one concern regarding the study and this relates to its acronym ‘VIDA’ (Viability Identification with Dipyridamole Administration). I am, as are the main authors, Italian and, in Italian, ‘vita’ means ‘life: perhaps a ‘t’ instead of a ‘d’ would have been more appropriate! R. FERRARI University of Ferrara, Italy References

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom